OUR RESEARCH & DEVELOPMENT
Servier invests more than 20% of its sales revenue
(excl. generic medicines) in R&D.
GLOBAL RESEARCH & DEVELOPMENT
To discover new treatments that improve patients’ lives, Servier invests more than 20% of its sales revenue (excl. generic medicines) in R&D. The Group focuses its research and development efforts in therapeutic areas where needs are substantial. Servier intends to dedicate +50% of its global R&D budget* to researching cancer treatments.
The establishment of the future Servier Paris Saclay Research Institute is a perfect illustration of our desire to pursue more open, agile, and productive research to serve patients.
+20%
of revenue from
brand-name
medicines invested
in R&D each year.
+50%
of its global R&D
budget* investments
to research cancer treatments.
*brand-name activity
+ than 40
active alliances
worldwide.
SERVIER PARIS-SACLAY RESEARCH INSTITUTE
Accelerating research today to reinvent health care tomorrow
For more information, please visit www.servier.com/paris-saclay-institute/
PORTFOLIO DEVELOPMENT
More information on Servier’s development portfolio can be found on www.servier.com/development-portfolio/
OUR RESEARCH & DEVELOPMENT CENTRE IN BELGIUM
” Servier R&D Benelux, created in 1988, is involved in the international development of our innovative treatments, and thus contributing to the scientific influence of our countries and enabling us to offer therapeutic solutions that meet patients’ needs.
As Clinical Operations Department, we set up and conduct clinical trials in Belgium, the Netherlands and Luxembourg in all Servier’s therapeutic areas. Each clinical trial is rigorously managed according to all international standards by an experienced team fully committed to therapeutic progress
for the benefit of the patients. ”
Dr. Arne Sakrauski, Clinical Operations Director Hub Europe
Are you an investigator or physician
interested to work with us in clinical trials in the Benelux?
Servier complies with European and American standards in terms of transparency in clinical trials.
The clinical reports of our studies are gradually made public and are used to obtain new marketing authorizations in Europe.The Servier clinical registry provides data protocol and results from our Phase I to IV clinical studies.
If you are interested in finding out more about ongoing clinical trials, you can consult our global clinical trial registers.
The EU Clinical Trials Register allows you to search for protocol and results information on: interventional clinical trials that are conducted in the European Union (EU) and the European Economic Area (EEA); and clinical trials conducted outside the EU / EEA that are linked to European paediatric-medicine development. For more information click here.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. For more information click here.